Figure 1
Outcomes of patients with CN-AML according to WT1 mutation status. DFS (A) and OS (B) of patients aged 60 years or older and of those younger than 60 years according to WT1 mutation status.

Outcomes of patients with CN-AML according to WT1 mutation status. DFS (A) and OS (B) of patients aged 60 years or older and of those younger than 60 years according to WT1 mutation status.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal